LeadStory

CNBC

Dr. Ashish Jha talks Novo Nordisk getting approval for Wegovy pill

CNBC · Just In
CNBC
CNBC
Just In

Dr. Ashish Jha, Brown School of Public Health, joins 'Closing Bell Overtime' to talk Novo Nordisk getting approval fro a Wegovy pill, sending its stock climbing.

Breakdown
  • GLP-1 drugs are highly effective for obesity and related diseases 14s
  • Oral GLP-1 drugs increase accessibility for those avoiding injections 41s
  • Novo Nordisk is first to market; Eli Lilly expected to follow soon 1m 5s
  • Initial healthcare costs will rise, but long-term health benefits expected 2m 8s
  • Widespread GLP-1 use could help people live longer, healthier lives 2m 56s